article

Continuous manufacturing: ICH Q13

Although steps have been taken to enable the implementation of continuous manufacturing in industry, a lack of global harmonisation in regulations has slowed the adoption of this promising emerging technology. Dave Elder discusses how ICH Q13 seeks to provide a harmonised approach to support this important initiative.

abstract colourful background

Historically, most active pharmaceutical ingredients (APIs) and drug products have been manufactured via batch-based processes. These multi-step, multi-vessel, lengthy procedures, frequently involving discrete, isolated intermediates are often scale-dependent. Process knowledge accrued at small scale often needs to be re-learned as the method is scaled up. However, recent advances in both manufacturing technology and supporting process analytical technology (PAT) have encouraged the pharmaceutical industry to contemplate replacing batch manufacturing with faster, more efficient continuous manufacturing processes. Here, the ‘product’ moves through the various manufacturing stages in a continuous, automated fashion with minimal intervention or stoppage of the process.1 Although process throughput is typically less than in the standard batch process, continuous manufacturing can operate 24/7 and achieve a similar capacity without the need for scale up by operating for longer time periods.











To read this article in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


*

*

*

*

*

*

*

*

2 responses to “Continuous manufacturing: ICH Q13”

  1. Every single line is full of meaning and kind of need for coming future. This blog is so much necessary for the related people. Really helpful for those who read it as me and very thanks to u for posting it. Best of luck.

  2. Excellent article capturing the essence of the challenges that lie ahead. Thank you also for the references.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Send this to a friend